[ET Net News Agency, 10 October 2025]  INNOCARE (09969) fell 9.9% to HK$14.98.
  It hits an intra-day low of HK$14.95, hitting an 1-month low, dipping below the 100-D 
SMA of HK$15.937, and an intra-day high of HK$16.75. The total shares traded was 41.62  
million, with a value of HK$644.78m. The active buy/sell ratio is 41:59, with net selling 
turnover of HK$114.87m. CHINA INNOVATION MARKET SER accounts for greatest net responsive  
buying turnover of HK$13.14m, with volume weighted average price of HK$15.471. CLSA LTD 
accounts for greatest net responsive selling turnover of HK$33.06m, with volume weighted  
average price of HK$15.303. The stock has fallen a combined 21% over the past 3 
consecutive trading days. 
  
          Basic Information 
          ================= 
  
  ----------------------------------
  Nominal   14.980 % Chg     -9.87% 
  High      16.750 Low       14.950 
  Shares Tr 41.62m Turnover 644.78m 
  10-D SMA  17.882 %H.V      82.372 
  20-D SMA  17.582 VWAP      15.493 
  50-D SMA  17.859 RSI14     34.525 
  ----------------------------------
Status: Dipping below the 100-D SMA, hitting an 1-month low, active buy/sell ratio is 
41:59, with net selling turnover of HK$114.87m, falling a combined 21% over the past 3  
consecutive trading days
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)           Price (HK$) Change (%) 
  ----------------------------------------------
  INNOCARE (09969)             14.98      -9.87 
  SINO BIOPHARM (01177)         7.96      +0.76 
  HENGRUI PHARMA (01276)       85.70      -2.39 
  3SBIO (01530)                28.42      -0.70 
  EVEREST MED (01952)          54.05      -3.48 
  WUXI XDC (02268)             73.65      -4.97 
  ASCENTAGE-B (06855)          74.00      +0.54 
  SKB BIO-B (06990)           494.20      -3.19 
  AKESO (09926)               129.00      -1.90 
  REMEGEN (09995)              96.15      -9.46 
  ----------------------------------------------
  (ed)